Perbedaan Tempo Scan Pacific Tbk. dan Zyrexindo Mandiri Buana Tbk.: Tempo Scan Pacific Tbk. diperdagangkan di Rp2.580 (kapitalisasi pasar 11,68 T, volume 24 jam 429,7 rb), sedangkan Zyrexindo Mandiri Buana Tbk. diperdagangkan di Rp129 (kapitalisasi pasar 173,33 M, volume 24 jam 1,04 jt). Perbedaan utamanya: Tempo Scan Pacific Tbk. jauh lebih besar — sekitar 67,4× kapitalisasi pasar Zyrexindo Mandiri Buana Tbk., dan Zyrexindo Mandiri Buana Tbk. lebih aktif diperdagangkan (1,04 jt vs 429,7 rb). Mana yang lebih baik tergantung tujuan investasimu.
| TSPC | ZYRX | |
|---|---|---|
Kapitalisasi Pasar | 11,68 T | 173,33 M |
Volume | 429,7 rb | 1,04 jt |
Lot | 4,3 rb | 10,41 rb |
Perputaran | 1,11 M | 134,49 jt |
Harga Rata-rata | 2.591,65 | 129,19 |
Nilai Transaksi | 1,11 M | 134,49 jt |
Harga Ekuilibrium Indikatif | 2.580 | 129 |
Volume Ekuilibrium Indikatif | 100 | 15 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Selengkapnya di halaman TSPC →PT Zyrexindo Mandiri Buana Tbk (the Company) is a limited liability company established in Indonesia based on Notarial Deed No. 43 of Jimmy Simanungkalit, S.H., on May 14, 1996. The Company commenced its commercial operations in 1996. The majority shareholder of the Company is Timothy Siddik
Selengkapnya di halaman ZYRX →